Global Cold, Cough, and Sore Throat Remedies Market Size  Emerging Trends, Growing At A CAGR of 3.6%, Finds Coherent Market Insights
SEATTLE, April 14, 2021, (PHARMIWEB) – Overview
Cold, cough, and sore throat medications only help to alleviate symptoms. The time it takes for a cold to develop is usually between 24 and 72 hours. Nasal inflammation, mild fever, sneezing, sore throat, lack of appetite, fatigue, irritability, and other symptoms are all manifestations of a cold.
In terms of size, the global cold, cough, and sore throat remedies market is expected to hit US$ 36,325.0 million in 2019 and US$ 46,869.6 million by 2027.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample of the report @ https://www.coherentmarketinsights.com/insight/request-sample/3381
The global cold, cough, and sore throat remedies market is expected to expand as more treatments are approved and launched. Xofluza (baloxavir marboxil) obtained supplementary New Drug Use clearance from the US Food and Drug Administration in October 2019 for the treatment of acute, uncomplicated influenza, or flu, in people aged 12 and up.
The implementation of attractive payment programmes is projected to provide market participants with profitable development opportunities. Humana Inc., launched an HMO package in New Jersey in October 2019 that includes an OTC quarterly allowance from Humana Pharmacy, which includes first-aid supplies, aspirin, and cold and allergy medications.
The market’s growth is likely to be hampered by strict regulatory guidelines. In February 2019, Health Canada released a precautionary action prohibiting the use of codeine, hydrocodone, and normethadone-containing drugs for the treatment of cough symptoms in infants.
Fake cough syrups are being sold in the market, which is likely to have a negative effect on market growth. Zimbabwe’s Medicines Control Authority warned the public in January 2020 that a falsified form of Flumed cough, cold, and flu syrup had been discovered in pharmacies.
In addition, the illicit selling of cough syrups has risen in developing markets. In Odisha, India, the district police department confiscated 8,000 bottles of cough syrup for illicit sale in January 2020.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/3381
Key companies contributing in the global cold, cough, and sore throat remedies market are Johnson & Johnson Services, Inc., Bayer AG, Reckitt Benckiser Group PLC, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Procter & Gamble Co.,Prestige Brands Holdings, Inc., Novartis AG, AstraZeneca plc, and GlaxoSmithKline plc.
Sanofi purchased the nonprescription rights to Roche’s Tamiflu in July 2019 in order to penetrate the US OTC cough, cold, and flu market.
Algernon Pharmaceuticals Inc. announced plans to initiate the first phase 2 clinical trial of NP-120 (Ifenprodil), a repurposed treatment for people with idiopathic pulmonary fibrosis and persistent cough, in December 2019.
By Drug Type:
- Oral Syrups
- Nasal Drops
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- E-Commerce/Online Pharmacies
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/cold-cough-and-sore-throat-remedies-market-2748
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights,
1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
- CDN Newswire